Microvascular and microangiopathic antiphospholipid-associated syndromes ("MAPS"): semantic or antisemantic?
about
Catastrophic antiphospholipid syndrome: how to diagnose a rare but highly fatal diseasePredictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experienceTask Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (II): thrombocytopenia and skin manifestations.Catastrophic APS in the context of other thrombotic microangiopathies.The significance and management of thrombocytopenia in antiphospholipid syndrome.Autoimmunity and recurrent pregnancy losses.Current knowledge regarding Asherson's syndrome.Management of women with recurrent pregnancy losses and antiphospholipid antibody syndrome.Antiphospholipid syndrome nephropathy (APSN) in patients with lupus nephritis: a retrospective clinical and renal pathology study.The beneficial effect of plasmapheresis in mixed connective tissue disease with coexisting antiphospholipid syndrome.Acute lupus myocarditis: Clinical features and outcome.Serum and organ-associated anti-hemoglobin humoral autoreactivity: association with anti-Sm responses and inflammation.Induction of anti-β2-glycoprotein I autoantibodies in mice by protein H of Streptococcus pyogenesAn approach to differential diagnosis of antiphospholipid antibody syndrome and related conditions
P2860
Q26825077-C64656E9-B2FF-445D-9222-E99540836E2DQ33389392-A1C86DD8-F76C-4D9A-98B5-538885E239B0Q33394044-A15C64ED-6914-45CC-BC86-52E3D93CB83CQ33419886-8F14BB79-AEE8-4EE6-96B3-FB4D8E15ED2BQ33420910-4A787391-BA89-4C5E-B8E6-B2321C955B58Q35008643-98681CB5-C126-44FF-A952-51792F29AF42Q37755290-2DE986F1-FE09-418B-99E4-5B7C7524DA7DQ38092150-12F711C3-75AE-4E8D-B505-55849D4C410EQ38162724-E5F42D1F-6D27-4BC1-B4CE-833CF9501BB3Q40188862-AB26FDEC-0BDC-4272-BCB1-BCC593E5D365Q45085063-F10E97BA-3AF7-4381-8A4E-F5F20CCFD286Q47970761-F2146981-15F3-4337-B8E8-407591B26554Q57983447-B8A43EFA-1D38-4BD0-95D8-6627B568D95EQ59075500-F6EF166F-0D97-4027-B0EE-29D77EDA9FCD
P2860
Microvascular and microangiopathic antiphospholipid-associated syndromes ("MAPS"): semantic or antisemantic?
description
2007 nî lūn-bûn
@nan
2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Microvascular and microangiopa ...... S"): semantic or antisemantic?
@ast
Microvascular and microangiopa ...... S"): semantic or antisemantic?
@en
type
label
Microvascular and microangiopa ...... S"): semantic or antisemantic?
@ast
Microvascular and microangiopa ...... S"): semantic or antisemantic?
@en
prefLabel
Microvascular and microangiopa ...... S"): semantic or antisemantic?
@ast
Microvascular and microangiopa ...... S"): semantic or antisemantic?
@en
P1433
P1476
Microvascular and microangiopa ...... S"): semantic or antisemantic?
@en
P304
P356
10.1016/J.AUTREV.2007.11.009
P577
2007-12-03T00:00:00Z